---
document_datetime: 2025-12-29 14:35:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zalviso.html
document_name: zalviso.html
version: success
processing_time: 0.1096201
conversion_datetime: 2025-12-30 22:49:12.843982
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zalviso

[RSS](/en/individual-human-medicine.xml/66557)

##### Withdrawn

This medicine's authorisation has been withdrawn

sufentanil Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Zalviso](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 5 August 2022, the European Commission withdrew the marketing authorisation for Zalviso (sufentanil) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, FGK Representative Service GmbH, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Zalviso was granted marketing authorisation in the EU on 18 September 2015 for the management of acute moderate to severe post-operative pain. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2020.

The European Public Assessment Report (EPAR) for Zalviso is updated to indicate that the marketing authorisation is no longer valid.

Zalviso : EPAR - Summary for the public

English (EN) (663.58 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 27/09/2022

[View](/en/documents/overview/zalviso-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-76)

български (BG) (760.64 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/bg/documents/overview/zalviso-epar-summary-public_bg.pdf)

español (ES) (667.71 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/es/documents/overview/zalviso-epar-summary-public_es.pdf)

čeština (CS) (739.15 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/cs/documents/overview/zalviso-epar-summary-public_cs.pdf)

dansk (DA) (665.9 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/da/documents/overview/zalviso-epar-summary-public_da.pdf)

Deutsch (DE) (670.41 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/de/documents/overview/zalviso-epar-summary-public_de.pdf)

eesti keel (ET) (665.35 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/et/documents/overview/zalviso-epar-summary-public_et.pdf)

ελληνικά (EL) (762.93 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/el/documents/overview/zalviso-epar-summary-public_el.pdf)

français (FR) (669.36 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fr/documents/overview/zalviso-epar-summary-public_fr.pdf)

hrvatski (HR) (686.42 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hr/documents/overview/zalviso-epar-summary-public_hr.pdf)

italiano (IT) (666.44 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/it/documents/overview/zalviso-epar-summary-public_it.pdf)

latviešu valoda (LV) (738.28 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lv/documents/overview/zalviso-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (688.61 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lt/documents/overview/zalviso-epar-summary-public_lt.pdf)

magyar (HU) (733.2 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hu/documents/overview/zalviso-epar-summary-public_hu.pdf)

Malti (MT) (741.01 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/mt/documents/overview/zalviso-epar-summary-public_mt.pdf)

Nederlands (NL) (667.09 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/nl/documents/overview/zalviso-epar-summary-public_nl.pdf)

polski (PL) (738.41 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pl/documents/overview/zalviso-epar-summary-public_pl.pdf)

português (PT) (668.03 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pt/documents/overview/zalviso-epar-summary-public_pt.pdf)

română (RO) (688.79 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/ro/documents/overview/zalviso-epar-summary-public_ro.pdf)

slovenčina (SK) (737.52 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sk/documents/overview/zalviso-epar-summary-public_sk.pdf)

slovenščina (SL) (730.65 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sl/documents/overview/zalviso-epar-summary-public_sl.pdf)

Suomi (FI) (665.44 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fi/documents/overview/zalviso-epar-summary-public_fi.pdf)

svenska (SV) (667.37 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sv/documents/overview/zalviso-epar-summary-public_sv.pdf)

Zalviso : EPAR - Risk-management-plan summary

English (EN) (656.57 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 27/09/2022

[View](/en/documents/rmp-summary/zalviso-epar-risk-management-plan-summary_en.pdf)

## Product information

Zalviso : EPAR - Product Information

English (EN) (1.16 MB - PDF)

**First published:** 02/10/2015

**Last updated:** 27/09/2022

[View](/en/documents/product-information/zalviso-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-836)

български (BG) (2.02 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/bg/documents/product-information/zalviso-epar-product-information_bg.pdf)

español (ES) (1.14 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/es/documents/product-information/zalviso-epar-product-information_es.pdf)

čeština (CS) (1.73 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/cs/documents/product-information/zalviso-epar-product-information_cs.pdf)

dansk (DA) (1.14 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/da/documents/product-information/zalviso-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/de/documents/product-information/zalviso-epar-product-information_de.pdf)

eesti keel (ET) (1.15 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/et/documents/product-information/zalviso-epar-product-information_et.pdf)

ελληνικά (EL) (2.07 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/el/documents/product-information/zalviso-epar-product-information_el.pdf)

français (FR) (1.17 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fr/documents/product-information/zalviso-epar-product-information_fr.pdf)

hrvatski (HR) (1.23 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hr/documents/product-information/zalviso-epar-product-information_hr.pdf)

íslenska (IS) (1.11 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/is/documents/product-information/zalviso-epar-product-information_is.pdf)

italiano (IT) (1.08 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/it/documents/product-information/zalviso-epar-product-information_it.pdf)

latviešu valoda (LV) (3.17 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lv/documents/product-information/zalviso-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.21 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lt/documents/product-information/zalviso-epar-product-information_lt.pdf)

magyar (HU) (1.8 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hu/documents/product-information/zalviso-epar-product-information_hu.pdf)

Malti (MT) (1.81 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/mt/documents/product-information/zalviso-epar-product-information_mt.pdf)

Nederlands (NL) (1.13 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/nl/documents/product-information/zalviso-epar-product-information_nl.pdf)

norsk (NO) (1.14 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/no/documents/product-information/zalviso-epar-product-information_no.pdf)

polski (PL) (1.77 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pl/documents/product-information/zalviso-epar-product-information_pl.pdf)

português (PT) (1.14 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pt/documents/product-information/zalviso-epar-product-information_pt.pdf)

română (RO) (1.24 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/ro/documents/product-information/zalviso-epar-product-information_ro.pdf)

slovenčina (SK) (1.72 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sk/documents/product-information/zalviso-epar-product-information_sk.pdf)

slovenščina (SL) (1.74 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sl/documents/product-information/zalviso-epar-product-information_sl.pdf)

Suomi (FI) (1.05 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fi/documents/product-information/zalviso-epar-product-information_fi.pdf)

svenska (SV) (1.14 MB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sv/documents/product-information/zalviso-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0017 05/08/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Zalviso : EPAR - All Authorised presentations

English (EN) (590.39 KB - PDF)

**First published:** 02/10/2015

**Last updated:** 27/09/2022

[View](/en/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-309)

български (BG) (630.83 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/bg/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_bg.pdf)

español (ES) (589.36 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/es/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_es.pdf)

čeština (CS) (612.66 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/cs/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (588.95 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/da/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (588.89 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/de/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (588.92 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/et/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (629.13 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/el/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_el.pdf)

français (FR) (589.08 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fr/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (600.21 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hr/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (588.96 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/is/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_is.pdf)

italiano (IT) (589.31 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/it/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (622.41 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lv/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (605.38 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/lt/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (618.12 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/hu/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (620.25 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/mt/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (589.22 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/nl/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (589.15 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/no/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_no.pdf)

polski (PL) (620.57 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pl/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_pl.pdf)

português (PT) (589.37 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/pt/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_pt.pdf)

română (RO) (606.42 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/ro/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (619.68 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sk/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (618.15 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sl/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (589.19 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/fi/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (589.02 KB - PDF)

**First published:**

02/10/2015

**Last updated:**

27/09/2022

[View](/sv/documents/all-authorised-presentations/zalviso-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Zalviso Active substance sufentanil International non-proprietary name (INN) or common name sufentanil Therapeutic area (MeSH) Pain, Postoperative Anatomical therapeutic chemical (ATC) code N01AH03

### Pharmacotherapeutic group

Anesthetics

### Therapeutic indication

Zalviso is indicated for the management of acute moderate to severe post-operative pain in adult patients.

## Authorisation details

EMA product number EMEA/H/C/002784 Marketing authorisation holder

FGK Representative Service GmbH

Heimeranstrasse 35

Opinion adopted 23/07/2015 Marketing authorisation issued 18/09/2015 Revision 7

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Zalviso : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (706.73 KB - PDF)

**First published:** 19/05/2016

**Last updated:** 27/09/2022

[View](/en/documents/procedural-steps-after/zalviso-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Zalviso-H-C-PSUSA-00002798-201811 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Adopted

Reference Number: EMA/425728/2019

English (EN) (657.2 KB - PDF)

**First published:** 09/10/2019

**Last updated:** 27/09/2022

[View](/en/documents/scientific-conclusion/zalviso-h-c-psusa-00002798-201811-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Zalviso : EPAR - Public assessment report

Adopted

Reference Number: EMA/612007/2015

English (EN) (4.53 MB - PDF)

**First published:** 02/10/2015

**Last updated:** 27/09/2022

[View](/en/documents/assessment-report/zalviso-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Zalviso

Adopted

Reference Number: EMA/CHMP/471000/2015

English (EN) (642.12 KB - PDF)

**First published:** 24/07/2015

**Last updated:** 27/09/2022

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-zalviso_en.pdf)

#### News on Zalviso

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2015) 24/07/2015

**This page was last updated on** 27/09/2022

## Share this page

[Back to top](#main-content)